These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 9563900

  • 21. Potentiating effect of obacunone from Dictamnus dasycarpus on cytotoxicity of microtuble inhibitors, vincristine, vinblastine and taxol.
    Jung H, Sok DE, Kim Y, Min B, Lee J, Bae K.
    Planta Med; 2000 Feb; 66(1):74-6. PubMed ID: 10705741
    [Abstract] [Full Text] [Related]

  • 22. Rhazinilam mimics the cellular effects of taxol by different mechanisms of action.
    David B, Sévenet T, Morgat M, Guénard G, Moisand A, Tollon Y, Thoison O, Wright M.
    Cell Motil Cytoskeleton; 1994 Feb; 28(4):317-26. PubMed ID: 7954858
    [Abstract] [Full Text] [Related]

  • 23. Identification of a novel taxol-sensitive kinase activity associated with the cytoskeleton.
    Wang Y, Duncan R, Ann DK, Hamm-Alvarez SF.
    Biochem Biophys Res Commun; 2000 Nov 02; 277(3):525-30. PubMed ID: 11061987
    [Abstract] [Full Text] [Related]

  • 24. Low potency of taxol at microtubule minus ends: implications for its antimitotic and therapeutic mechanism.
    Derry WB, Wilson L, Jordan MA.
    Cancer Res; 1998 Mar 15; 58(6):1177-84. PubMed ID: 9515803
    [Abstract] [Full Text] [Related]

  • 25. Pharmacodynamics of immediate and delayed effects of paclitaxel: role of slow apoptosis and intracellular drug retention.
    Au JL, Li D, Gan Y, Gao X, Johnson AL, Johnston J, Millenbaugh NJ, Jang SH, Kuh HJ, Chen CT, Wientjes MG.
    Cancer Res; 1998 May 15; 58(10):2141-8. PubMed ID: 9605758
    [Abstract] [Full Text] [Related]

  • 26. Paclitaxel (Taxol) upregulates expression of functional interleukin-6 in human ovarian cancer cells through multiple signaling pathways.
    Wang TH, Chan YH, Chen CW, Kung WH, Lee YS, Wang ST, Chang TC, Wang HS.
    Oncogene; 2006 Aug 10; 25(35):4857-66. PubMed ID: 16547493
    [Abstract] [Full Text] [Related]

  • 27. Effects of microtubule inhibitors on etoposide accumulation and DNA damage in human K562 cells in vitro.
    Yalowich JC.
    Cancer Res; 1987 Feb 15; 47(4):1010-5. PubMed ID: 2879622
    [Abstract] [Full Text] [Related]

  • 28. Effects of taxol on microtubule organization in mouse splenic lymphocytes and on response to mitogenic stimulation.
    Brown DL, Little JE, Chaly N, Schweitzer I, Paulin-Levasseur M.
    Eur J Cell Biol; 1985 May 15; 37():130-9. PubMed ID: 2863144
    [Abstract] [Full Text] [Related]

  • 29. Androgen and taxol cause cell type-specific alterations of centrosome and DNA organization in androgen-responsive LNCaP and androgen-independent DU145 prostate cancer cells.
    Schatten H, Ripple M, Balczon R, Weindruch R, Chakrabarti A, Taylor M, Hueser CN.
    J Cell Biochem; 2000 Jan 15; 76(3):463-77. PubMed ID: 10649443
    [Abstract] [Full Text] [Related]

  • 30. Potent reversal of multidrug resistance by ningalins and its use in drug combinations against human colon carcinoma xenograft in nude mice.
    Chou TC, Guan Y, Soenen DR, Danishefsky SJ, Boger DL.
    Cancer Chemother Pharmacol; 2005 Oct 15; 56(4):379-90. PubMed ID: 15875185
    [Abstract] [Full Text] [Related]

  • 31. Synergistic interaction between topotecan and microtubule-interfering agents.
    Bahadori HR, Green MR, Catapano CV.
    Cancer Chemother Pharmacol; 2001 Sep 15; 48(3):188-96. PubMed ID: 11592339
    [Abstract] [Full Text] [Related]

  • 32. Measuring the complexity of cell cycle arrest and killing of drugs: kinetics of phase-specific effects induced by taxol.
    Sena G, Onado C, Cappella P, Montalenti F, Ubezio P.
    Cytometry; 1999 Oct 01; 37(2):113-24. PubMed ID: 10486523
    [Abstract] [Full Text] [Related]

  • 33. Bcl-xL is phosphorylated in malignant cells following microtubule disruption.
    Poruchynsky MS, Wang EE, Rudin CM, Blagosklonny MV, Fojo T.
    Cancer Res; 1998 Aug 01; 58(15):3331-8. PubMed ID: 9699663
    [Abstract] [Full Text] [Related]

  • 34. Effect of taxol on vinblastine sulfate-induced crystallization of tubulin.
    Ohta S, Krishan A, Nishio K, Ohmori T, Kunikane H, Inomata M, Takahashi T, Saijo N.
    Anticancer Res; 1993 Aug 01; 13(4):873-7. PubMed ID: 7688938
    [Abstract] [Full Text] [Related]

  • 35. Alteration of lymphocyte microtubule assembly, cytotoxicity, and activation by the anticancer drug taxol.
    Chuang LT, Lotzová E, Heath J, Cook KR, Munkarah A, Morris M, Wharton JT.
    Cancer Res; 1994 Mar 01; 54(5):1286-91. PubMed ID: 7907000
    [Abstract] [Full Text] [Related]

  • 36. Serine protease inhibitor TPCK prevents Taxol-induced cell death and blocks c-Raf-1 and Bcl-2 phosphorylation in human breast carcinoma cells.
    Huang Y, Sheikh MS, Fornace AJ, Holbrook NJ.
    Oncogene; 1999 Jun 10; 18(23):3431-9. PubMed ID: 10376521
    [Abstract] [Full Text] [Related]

  • 37. Blockade of mitogen-activated protein kinase cascade signaling in interleukin 6-independent multiple myeloma cells.
    Ogata A, Chauhan D, Urashima M, Teoh G, Treon SP, Anderson KC.
    Clin Cancer Res; 1997 Jun 10; 3(6):1017-22. PubMed ID: 9815779
    [Abstract] [Full Text] [Related]

  • 38. Novel actions of the antitumor drugs vinflunine and vinorelbine on microtubules.
    Ngan VK, Bellman K, Panda D, Hill BT, Jordan MA, Wilson L.
    Cancer Res; 2000 Sep 15; 60(18):5045-51. PubMed ID: 11016627
    [Abstract] [Full Text] [Related]

  • 39. Taxol differentially modulates the dynamics of microtubules assembled from unfractionated and purified beta-tubulin isotypes.
    Derry WB, Wilson L, Khan IA, Luduena RF, Jordan MA.
    Biochemistry; 1997 Mar 25; 36(12):3554-62. PubMed ID: 9132006
    [Abstract] [Full Text] [Related]

  • 40. Suppression of centromere dynamics by Taxol in living osteosarcoma cells.
    Kelling J, Sullivan K, Wilson L, Jordan MA.
    Cancer Res; 2003 Jun 01; 63(11):2794-801. PubMed ID: 12782584
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.